levetiracetam / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

35 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levetiracetam / Generic mfg.
ACTRN12608000293369: Intravenous Levetiracetam in the Acute Management of Seizures

Not yet recruiting
4
20
 
Prof. David C. Reutens, UCB Pharma
acute seizures
 
 
ACTRN12606000102572: Neuropsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.

Recruiting
4
200
 
Associate Prof. Terence O'Brien and RMH Neurosciences Foundation, UCB Pharma Belgium
Epilepsy
 
 
ACTRN12615000643572: EpiNet-First Trial 1: Comparison of efficacy of levetiracetam, lamotrigine and carbamazepine in people with previously untreated epilepsy who have focal seizures.

Recruiting
4
1467
 
EpiNet Study Group, Health Research Council of New Zealand, Neurological Foundation of New Zealand, Julius Brendel Trust
Epilepsy
 
 
ChiCTR-TRC-13003743: Anti-epilepsy drugs prophylaxis in cranioplasty for patients with skull defection: A prospective randomized controlled study

Completed
4
200
 
levetiracetam prophylaxis vs without levetiracetam prophylaxis
The First Affiliated Hospital of PLA General Hospital; Level of the institution:, Research funds
Epilepsy
 
 
2012-001884-64: A study of Standard and New Antiepileptic Drugs – SANAD-II.

Ongoing
4
1510
Europe
Sodium Valproate, Lamotrigine, Levetiracetam, Zonisamide, Tablet, Capsule, hard, Lamictal, Keppra, Zonegran
University of Liverpool, The Walton Centre NHS Foundation Trust, National Institute for Health Research (NIHR) Health Technology Assessment Program (HTA)
Epilepsy, Brain disorder, Diseases [C] - Nervous System Diseases [C10]
 
 
ChiCTR-OCC-11001874: Evaluate the efficacy and safety of Levetiracetam for prophylaxis and treatment of febrile seizure in children

Completed
4
67
 
NA ;starting dose with LEV 30mg/kg
PLA General Hospital; PLA General Hospital, NA
febrile seizure
 
 
2014-002188-13: Emergency treatment with levetiracetam or phenytoin in status epilepticus in children (EcLiPSE) - a randomsied unblinded controlled trial

Ongoing
4
308
Europe
Levetiracetam, Phenytoin, Concentrate for solution for infusion, Keppra, Epanutin
University of Liverpool, Alder Hey Children's NHS Foundation Trust, National Institute Health Research Health Technology Assessment (NETSCC), ational Institute Health Research Health Technology Assessment (NETSCC)
Convulsive Status Epilepticus, A convulsive seizure which continues for a prolonged period (longer than five minutes), or when convulsive seizures occur one after the other with no recovery between., Diseases [C] - Nervous System Diseases [C10]
 
 
2004-002114-11: A double blind, randomized, placebo-controlled, cross-over study to evaluate the effects of Levetiracetam on membrane excitability properties of afferent myelinated and unmyelinated fibers and change in neuropathic pain in patients with painful traumatic nerve injury.

Ongoing
4
20
Europe
Levetiracetam, - Keppra 250mg, - Keppra 500mg, - Keppra 250mg, - Keppra 500mg
Infociencia Clinical Research
Neuropathic pain due to a traumatic nerve lesion
 
 
2005-001516-41: Efficacy and safety of Levetiracetam treatment in patients suffering from Restless Legs SyndromeEficacia y seguridad de un tratamiento con levetiracetam en pacientes con síndrome idiopático de piernas inquietas

Ongoing
4
12
Europe
Levetiracetam, Keppra 250, Keppra 500, Keppra 250, Keppra 500
Clínica Plató Fundació Privada
Restless legs syndrome (RLS)
 
 
2005-002041-40: Double-blind, placebo controlled cross-over study to assess efficacy of Levetiracetam in paediatric and childhood Tourette syndrome. Estudio cruzado, aleatorizado, doble ciego controlado con placebo, para evaluar la eficacia del Levetiracetam en el control de los tics de pacientes pediátricos y adolescentes con síndrome de Gilles de la Tourette

Ongoing
4
20
Europe
Levetiracetam, Keppra 250 mg, Keppra 500 mg, Keppra 250 mg, Keppra 500 mg
Hospital Sant Joan de Déu
Tourette syndrome
 
 
2005-002042-19: Double-blind, placebo controlled cross-over study to assess the efficacy of Levetiracetam in paediatric and childhood non-epileptic myoclonusEstudio cruzado, aleatorizado, doble ciego controlado con placebo, para evaluar la eficacia del Levetiracetam en el tratamiento del mioclonus no epiléctico en pacientes pediátricos y adolescentes

Ongoing
4
20
Europe
Levetiracetam, Keppra 250 mg, Keppra 500 mg, Keppra 250 mg, Keppra 500 mg
Hospital Sant Joan de Déu
Non-epileptic myoclonus
 
 
2005-002474-30: Influence of levetiracetam on gamma band activity in a group of epilepsy patientsEstudio sobre la influencia de levetiracetam en la actividad de las ondas gamma en pacientes con epilepsia

Ongoing
4
25
Europe
Levetiracetam, Keppra 500mg, Keppra 1000mg, Keppra 500mg, Keppra 1000mg
Hospital Ruber Internacional
Epilepsy with partial and/or generalized seizures
 
 
2005-003903-35: : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis

Ongoing
4
20
Europe
Keppra ®, Keppra 250mg, Keppra 500mg
Newcastle-upon-Tyne Hospitals NHS Trust
Multiple Sclerosis
 
 
2005-003411-75: Estudio sobre la utilización de levetiracetam en monoterapia en pacientes HIV-positivos con epilepsia

Ongoing
4
20
Europe
levetiracetam, ucb-L059, Keppra 500 / 1000 mg comprimidos con cubierta pelicular, Keppra 500 / 1000 mg comprimidos con cubierta pelicular
Fundación para la Investigación Biomédica del Hospital Clínico de San Carlos
Pacientes HIV-positivos con epilepsia
 
 
2008-000370-20: Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders.

Ongoing
4
24
Europe
Lamotrigine, Gabapentin, Carbamazepine, Oxcarbazepine, Levetiracetam, Valproic acid, CIPRALEX, LITIO CARBONATO, CIPRALEX, LITIO CARBONATO
AZIENDA OSPEDALIERA PISANA
bipolar disorders
 
 
2011-005971-18: TTS (Time To Stop) Trial

Ongoing
4
40
Europe
carbamazepine, Levetiracetam, Lamotrigine, RVG 11401 (tabletten 100 mg), RVG 03899 (tabletten, RVG 29546, We won\'t be investigating a specific IMP but a group of antiepileptic drugs to be withdrawn earlier after epilepsy surgery. The earlier withdrawal is the research question. As discussed 3 IMPs wille be given; carbamazepine, Levetiracetam, Lamotrigine, We won\'t be investigating a specific IMP but a group of antiepileptic drugs to be withdrawn earlier after epilepsy surgery. The earlier withdrawal is the research question. As discussed 3 IMPs wille be given; carbamazepine, Levetiracetam, Lamotrigine
University Medical Center Utrecht, Dutch national epilepsy fund
We will investigate possible cognitive benifits of early antiepileptic drug withdrawal after pediatric epilepsy surgery. The concerning medical condition is refractory epilepsy
 
 
2015-004827-30: Rapid versus slow withdrawal of antiepileptci monotherapy in two-year seizure free patients. Sospensione rapida contro sospensione lenta della monoterapia con un farmaco antiepilettico in pazienti senza crisi da almeno due anni

Ongoing
4
350
Europe
Tablet, KEPPRA - 1000MG-COMPRESSA RIVESTITA CON FILM-USO ORALE BLISTER DIVISIBILE (ALLUMINIO/PVC)-100X1 (DOSE UNITARIA)
AZIENDA OSPEDALIERA "BIANCHI-MELACRINO-MORELLI", Ministero della Salute, REGIONE CALABRIA
Epilepsy Epilessia, Epilepsy Epilessia, Diseases [C] - Nervous System Diseases [C10]
 
 
2018-000781-10: EFFICACY AND TOLERABILITY OF LOW versus STANDARD DAILY DOSES OF ANTIEPILEPTIC DRUGS IN NEWLY DIAGNOSED, PREVIOUSLY UNTREATED EPILEPSY Efficacia e tollerabilit¿ di basse dosi contro dosi standard dei farmaci antiepilettici in pazienti non trattati di nuova diagnosi.

Not yet recruiting
4
374
Europe
CARBAMAZEPINA, OXCARBAZEPINA, LAMOTRIGINA, LEVETIRACETAM, TOPIRAMATO, ACIDO VALPROICO, GABAPENTIN, ZONISAMIDE, CARBAMAZEPINA BASSA DOSE, OXCARBAZEPINA BASSA DOSE, LAMOTRIGINA BASSA DOSE, LEVETIRACETAM BASSA DOSE, TOPIRAMATO BASSA DOSE, ACIDO VALPROICO BASSA DOSE, GABAPENTIN BASSA DOSE, ZONISAMIDE BASSA DOSE, CARBAMAZEPINA, OXCARBAZEPINA, LAMOTRIGINA, LEVETIRACETAM, TOPIRAMATO, ACIDO VALPROICO, GABAPENTIN, ZONISAMIDE, CARBAMAZEPINA BASSA DOSE, OXCARBAZEPINA BASSA DOSE, LAMOTRIGINA BASSA DOSE, LEVETIRACETAM BASSA DOSE, TOPIRAMATO BASSA DOSE, ACIDO VALPROICO BASSA DOSE, GABAPENTIN BASSA DOSE, ZONISAMIDE BASSA DOSE, Tablet, Capsule, hard, TEGRETOL - 200 MG COMPRESSE A RILASCIO MODIFICATO 30 COMPRESSE, TOLEP - 300 MG COMPRESSE 50 COMPRESSE DIVISIBILI, LAMOTRIGINA DOC - 100 MG COMPRESSE DISPERSIBILI 56 COMPRESSE IN BLISTER ACLAR/PVC/AL, LEVETIRACETAM DOC - 500 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE, TOPIRAMATO DOC GENERICI - 100 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN BLISTER AL/AL, ACIDO VALPROICO SANDOZ - 300 MG COMPRESSE A RILASCIO PROLUNGATO30 COMPRESSE, GABAPENTIN MYLAN GENERICS - 400 MG CAPSULE RIGIDE 500 (5X100) CAPSULE IN BLISTER PVC/ALU CONFEZIONE OSPEDALIERA, ZONEGRAN - 100 MG CAPSULA RIGIDA USO ORALE BLISTER (PVC/ALL) 196 CAPSULE
IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI, Ministero della Salute, Regione Lombardia
EPILEPSY EPILESSIA, EPILEPSY EPILESSIA, Diseases [C] - Nervous System Diseases [C10]
 
 
ChiCTR-IPR-15007241: Intermittent oral levetiracetam preventing the recurrence of febrile seizure with epileptiform discharges under the monitoring of iThermonitor: a multicenter randomized controlled trail

Not yet recruiting
4
400
 
LEV 15-30mg/kg ;NA
Chinese PLA General Hospital; PLA General Hospital, NA
febrile seizure
 
 
ACTRN12615000556549: EpiNet-First Trial 2: Comparison of efficacy of levetiracetam and sodium valproate in people with previously untreated epilepsy who have generalised seizures.

Terminated
4
506
 
EpiNEt Study Group, Health Research Council of New Zealand;, Neurological Foundation of New Zealand, Julius Brendel Trust
Epilepsy
 
 
ACTRN12615000641594: EpiNet-First Trial 5: Comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have unclassified seizures, and for whom sodium valporate is not deemed an acceptable anti-epileptic drug.

Terminated
4
664
 
EpiNet Study Group, Health Research Council of New Zealand, Neurological Foundation of New Zealand, Julius Brendel Trust
Epilepsy
 
 
ACTRN12615000640505: EpiNet-First Trial 4: Comparison of efficacy of levetiracetam, lamotrigine and sodium valproate in people with previously untreated epilepsy who have unclassified seizures.

Terminated
4
1176
 
EpiNet Study Group, Health Research Council of New Zealand, Neurological Foundation of New Zealand, Julius Brendel Trust
Epilepsy
 
 
ACTRN12615000639527: EpiNet-First Trial 3: Comparison of efficacy of levetiracetam and lamotrigine in people with previously untreated epilepsy who have generalised seizures, and for whom sodium valporate is not deemed an acceptable anti-epileptic drug.

Terminated
4
664
 
EpiNet Study Group, Health Research Council of New Zealand, Neurological Foundation of New Zealand, Julius Brendel Trust
Epilepsy
 
 
NCT04829838: Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus

Recruiting
4
244
RoW
intravenous levetireacetam
ayesha tariq, King Edward Medical University
Status Epilepticus
07/21
07/21
ChiCTR2200057041: Cost-effectiveness analysis of domestic and imported levetiracetam tablets in the treatment of children with focal epilepsy (real world study)

Not yet recruiting
4
80
 
Domestic levetiracetam treatment ;Imported levetiracetam treatment
Beijing Children's Hospital, Capital Medical University; Beijing Children's Hospital, Capital Medical University, none
Focal epilepsy in children
 
 
ChiCTR2000030052: A single prospective randomized controlled clinical trial of antiepileptic drug regimen for glioma patients with non-preoperative epilepsy

Not yet recruiting
4
100
 
take levetiracetam for 1 week ;take levetiracetam for 4 weeks
Beijing Tiantan Hospital, Capital Medical University; Beijing Tiantan Hospital, Capital Medical University, Beijing Natural Science Foundation
Glioma related epilepsy
 
 
ChiCTR2000030228: A single prospective randomized controlled clinical trial for antiepileptic drug regimen in the treatment of patients with glioma-related epilepsy

Not yet recruiting
4
100
 
levetiracetam for 6 months ;levetiracetam for 12 months
Beijing Tiantan Hospital, Capital Medical University; Beijing Tiantan Hospital, Capital Medical University, Beijing Natural Science Foundation
Glioma-related epilepsy
 
 
NCT06403150: The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus

Enrolling by invitation
4
62
RoW
Levetiracetam Injection, Iracet Injection, Neurocet Injection, Fosphenytoin Injection, Fosfen Injection
Dhaka Medical College
Status Epilepticus
08/24
10/24
2020-004878-22: Pharmacokinetic and Placental Transfer of Levetiracetam Etude de la pharmacocinétique maternelle et du passage transplacentaire du Lévétiracétam

Not yet recruiting
4
50
Europe
Film-coated tablet
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, DGOS
Epilepsy in pregnancy l'épilepsie pendant la grossesse, Epilepsy in pregnancy l'épilepsie pendant la grossesse, Diseases [C] - Nervous System Diseases [C10]
 
 
SPAR, NCT01801072: Seizure Prophylaxis in Aneurysm Repair

Completed
4
79
US
Levetiracetam, Keppra
University of Michigan
Intracranial Aneurysms, Seizure
10/23
10/23
GENESIS, NCT04759196: Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas

Recruiting
4
56
Canada
Topamax, Topiramate, TPM, Levetiracetam, LEV, Keppra
Université de Sherbrooke
Chronic Subdural Hematoma, Epilepsy; Seizure, Cortical Depression; Cortical Depolarization, Nonepileptic, Stereotypical and Intermittent Symptoms, NESIS
09/24
12/24
NCT06081283: Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

Recruiting
4
54
US
Phenobarbital Sodium Injection, phenobarbital, Levetiracetam, Lacosamide Injectable Product, Valproate Sodium, Valproate, Phosphenytoin
University of North Carolina, Chapel Hill
Brain Injuries, Acute, Brain Injuries, Traumatic, Brain Ischemia, Brain Hypoxia, Hypoxia-Ischemia, Brain, Heart Arrest, Stroke, Intracranial Hemorrhages, Coma, Persistent Vegetative State
11/24
02/25
NCT05969054: Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy

Recruiting
4
140
RoW
Lacosamide 100 mg, Levetiracetam 250mg
Xiangya Hospital of Central South University
Alzheimer Disease 3, Epilepsy
12/25
12/25
STING, NCT03048084: Seizure Treatment in Glioma

Recruiting
4
120
Europe
Levetiracetam, Keppra, Valproic Acid, Depakine
Leiden University Medical Center, Medical Center Haaglanden, Erasmus Medical Center, Amsterdam UMC, location VUmc
Glioma
01/26
01/28
NCT05737511: Efficacy of Hydroxyzine for Patients With Panic Disorder

Not yet recruiting
4
80
NA
Hydroxyzine, Atarax, Vistaril, Escitalopram Oxalate, citalopram, fluoxetine, fluvoxamine, paroxetine, paroxetine CR, sertraline, venlafaxine XR,, Alprazolam, clomipramine, clonazepam, diazepam, imipramine, lorazepam, mirtazapine, reboxetine, Bupropion SR, divalproex, duloxetine, gabapentin, levetiracetam, milnacipran, moclobemide, olanzapine, phenelzine, quetiapine, risperidone, tranylcypromine
Sultan Qaboos University
Panic Disorder
12/26
12/26

Download Options